Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paraneoplastic pemphigus

G J Anhalt1

  • 1Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Advances in Dermatology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Paraneoplastic pemphigus is a distinct autoimmune syndrome linked to rare lymphoreticular cancers. Identifying the specific antigens and disease mechanisms is crucial for developing better treatments for this devastating condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti-CD 20 monoclonal antibodies.

The British journal of dermatology·2019
Same author

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.

Clinical and experimental immunology·2010
Same author

Treatment of pyoderma gangrenosum with intravenous immunoglobulin.

The British journal of dermatology·2007
Same author

Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption.

The Journal of clinical endocrinology and metabolism·2006
Same author

Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.

Clinical and experimental immunology·2005
Same author

Paraneoplastic pemphigus in a dog with splenic sarcoma.

Veterinary pathology·2005
Same journal

Uncommon benign infantile vascular tumors.

Advances in dermatology·2009
Same journal

Advances in hair diseases.

Advances in dermatology·2009
Same journal

Cutaneous mosaicism: a molecular and clinical review.

Advances in dermatology·2009
Same journal

Current concepts: dermatopathology of pigmentary alteration disorders in the Hispanic population.

Advances in dermatology·2009
Same journal

Recent advances in acne vulgaris research: insights and clinical implications.

Advances in dermatology·2009
Same journal

Update on the natural history and systemic treatment of psoriasis.

Advances in dermatology·2009
See all related articles

Area of Science:

  • Immunodermatology
  • Oncology
  • Autoimmune Diseases

Background:

  • Paraneoplastic pemphigus (PNP) is a newly recognized autoimmune blistering disease.
  • It presents with unique clinical, histological, and immunopathological features.
  • PNP is strongly associated with specific lymphoreticular malignancies.

Observation:

  • The restricted association suggests a common mechanism linking tumors to autoimmunity.
  • Uncharacterized protein antigens are implicated in the disease pathogenesis.
  • Tumor cells appear to drive the autoimmune response.

Findings:

  • The exact nature of the autoantigens in paraneoplastic pemphigus remains to be identified.
  • Potential autoantigens may include epithelial adhesion molecules.

Related Experiment Videos

  • The precise mechanisms by which tumors induce autoimmunity are yet to be fully elucidated.

    • Implications:

    • Understanding PNP pathogenesis could inform treatments for other paraneoplastic syndromes, such as autoimmune cytopenias and myasthenia gravis.
    • Identification of autoantigens may lead to targeted therapies.
    • Improved understanding of disease mechanisms offers hope for better management of this high-mortality condition.